As of 2025-05-21, the Fair Value of aTyr Pharma Inc (LIFE) is -3.65 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.90 USD, the upside of aTyr Pharma Inc is -292.15%.
With the market price of 1.90 USD and our fair value calculation, aTyr Pharma Inc (LIFE) is not a good investment. Investing in LIFE stocks now will result in a potential loss of 292.15%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | - | - | 5Y Avg | |
| Net income | -45.34 | -50.39 | - | - | -47.86 | |
| YoY growth | -34.26% | -11.14% | - | - | -22.70% | |
| Market Cap (mil) | 131.12 |
| P/E | |
| Forward P/E |
| EPS | -0.73 |
| Avg earnings growth rate | -22.70% |
| TTM earnings | -50.39 |